Published in J Allergy Clin Immunol on April 16, 2007
A summary of the new GINA strategy: a roadmap to asthma control. Eur Respir J (2015) 1.82
Provider demonstration and assessment of child device technique during pediatric asthma visits. Pediatrics (2011) 1.07
Long-term maintenance of pharmacists' inhaler technique demonstration skills. Am J Pharm Educ (2009) 1.04
The challenge of delivering therapeutic aerosols to asthma patients. ISRN Allergy (2013) 0.91
Comparison of small-group training with self-directed internet-based training in inhaler techniques. Am J Pharm Educ (2009) 0.86
Self-management behaviors in older adults with asthma: associations with health literacy. J Am Geriatr Soc (2014) 0.85
Development and evaluation of an innovative model of inter-professional education focused on asthma medication use. BMC Med Educ (2014) 0.83
The effect of using simulation for training pharmacy students on correct device technique. Am J Pharm Educ (2014) 0.82
Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients. Int J Chron Obstruct Pulmon Dis (2013) 0.82
The GINA asthma strategy report: what's new for primary care? NPJ Prim Care Respir Med (2015) 0.82
Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients. J Aerosol Med Pulm Drug Deliv (2013) 0.82
The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review. Pharm Pract (Granada) (2013) 0.80
Inter-professional education unveiling significant association between asthma knowledge and inhaler technique. Pharm Pract (Granada) (2016) 0.80
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting. J Asthma (2016) 0.80
Exploring the role of quantitative feedback in inhaler technique education: a cluster-randomised, two-arm, parallel-group, repeated-measures study. NPJ Prim Care Respir Med (2014) 0.79
Are children with asthma overconfident that they are using their inhalers correctly? J Asthma (2015) 0.79
Role of community pharmacists in asthma - Australian research highlighting pathways for future primary care models. Australas Med J (2011) 0.78
Empowering family physicians to impart proper inhaler teaching to patients with chronic obstructive pulmonary disease and asthma. Can Respir J (2015) 0.78
Inhaler technique: facts and fantasies. A view from the Aerosol Drug Management Improvement Team (ADMIT). NPJ Prim Care Respir Med (2016) 0.75
Use of simulated patient approach to assess the community pharmacists' knowledge of appropriate use of metered dose inhaler. J Basic Clin Pharm (2016) 0.75
An exploration of clinical interventions provided by pharmacists within a complex asthma service. Pharm Pract (Granada) (2015) 0.75
The economic burden of asthma and chronic obstructive pulmonary disease and the impact of poor inhalation technique with commonly prescribed dry powder inhalers in three European countries. BMC Health Serv Res (2016) 0.75
Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey. J Thorac Dis (2016) 0.75
Practice makes perfect: self-reported adherence a positive marker of inhaler technique maintenance. NPJ Prim Care Respir Med (2017) 0.75
Exploring the influence of patient-provider communication on intraocular pressure in glaucoma patients. Patient Educ Couns (2015) 0.75
Evaluation of the community pharmacist's behavior towards a prescription of antidiabetic and antiasthma drugs. Pharm Pract (Granada) (2011) 0.75
The Danish National Database for Asthma: establishing clinical quality indicators. Eur Clin Respir J (2016) 0.75
Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers? J Aerosol Med Pulm Drug Deliv (2016) 0.75
Effect of novel inhaler technique reminder labels on the retention of inhaler technique skills in asthma: a single-blind randomized controlled trial. NPJ Prim Care Respir Med (2017) 0.75
Pharmacists' perspectives of the current status of pediatric asthma management in the U.S. community pharmacy setting. Int J Clin Pharm (2017) 0.75
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Clinical control of asthma associates with measures of airway inflammation. Thorax (2012) 2.15
Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care (2005) 1.94
User error with Diskus and Turbuhaler by asthma patients and pharmacists in Jordan and Australia. Respir Care (2011) 1.67
The insomnia patient perspective, a narrative review. Behav Sleep Med (2013) 1.48
Predicting future risk of asthma exacerbations using individual conditional probabilities. J Allergy Clin Immunol (2011) 1.46
Primary health care teams and the patient perspective: a social network analysis. Res Social Adm Pharm (2013) 1.45
Overall asthma control: the relationship between current control and future risk. J Allergy Clin Immunol (2010) 1.41
Evaluation of a novel educational strategy, including inhaler-based reminder labels, to improve asthma inhaler technique. Patient Educ Couns (2008) 1.37
Metered-dose inhaler technique: the effect of two educational interventions delivered in community pharmacy over time. J Asthma (2010) 1.35
Complementary and alternative medicine use in asthma: who is using what? Respirology (2006) 1.30
Pharmacists' perceptions of their role in asthma management and barriers to the provision of asthma services. Int J Pharm Pract (2010) 1.28
IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM. Am J Physiol Lung Cell Mol Physiol (2006) 1.20
Impact on medication use and adherence of Australian pharmacists' diabetes care services. J Am Pharm Assoc (2003) (2005) 1.13
Patient preferences for managing asthma: results from a discrete choice experiment. Health Econ (2007) 1.12
The effect of inhaled IFN-β on worsening of asthma symptoms caused by viral infections. A randomized trial. Am J Respir Crit Care Med (2014) 1.11
CD40 and OX40 ligand are increased on stimulated asthmatic airway smooth muscle. J Allergy Clin Immunol (2005) 1.08
RAGE and TLRs: relatives, friends or neighbours? Mol Immunol (2013) 1.05
Long-term maintenance of pharmacists' inhaler technique demonstration skills. Am J Pharm Educ (2009) 1.04
RAGE: a new frontier in chronic airways disease. Br J Pharmacol (2012) 1.04
The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med (2015) 1.00
Treating asthma with a self-management model of illness behaviour in an Australian community pharmacy setting. Soc Sci Med (2007) 1.00
Using the community pharmacy to identify patients at risk of poor asthma control and factors which contribute to this poor control. J Asthma (2011) 0.99
Eosinophilic inflammation in subjects with mild-to-moderate asthma with and without obesity: disparity between sputum and biopsies. Am J Respir Crit Care Med (2014) 0.98
IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability. J Allergy Clin Immunol (2004) 0.97
The reliability and patient acceptability of the SmartTrack device: a new electronic monitor and reminder device for metered dose inhalers. J Asthma (2012) 0.97
Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial. J Asthma (2012) 0.97
The validity and reliability of two asthma knowledge questionnaires. J Asthma (2005) 0.96
Interactive small-group asthma education in the community pharmacy setting: a pilot study. J Asthma (2007) 0.93
Multidisciplinary collaboration in primary care: through the eyes of patients. Aust J Prim Health (2013) 0.93
Effect of budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med (2002) 0.92
Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res (2011) 0.91
Asthmatic airway smooth muscle CXCL10 production: mitogen-activated protein kinase JNK involvement. Am J Physiol Lung Cell Mol Physiol (2012) 0.91
A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: Study Protocol. Implement Sci (2012) 0.91
Asthma: time to confront some inconvenient truths. Respirology (2010) 0.89
'Proliferative' and 'synthetic' airway smooth muscle cells are overlapping populations. Immunol Cell Biol (2004) 0.89
Exasperations" of asthma: a qualitative study of patient language about worsening asthma. Med J Aust (2006) 0.87
Obesity and asthma control in an urban population. J Allergy Clin Immunol (2010) 0.86
Comparison of small-group training with self-directed internet-based training in inhaler techniques. Am J Pharm Educ (2009) 0.86
Using discrete choice experiments to investigate subject preferences for preventive asthma medication. Respirology (2007) 0.85
Short-term variability of airway caliber-a marker of asthma? J Appl Physiol (1985) (2007) 0.85
Corticosteroids inhibit sphingosine 1-phosphate-induced interleukin-6 secretion from human airway smooth muscle via mitogen-activated protein kinase phosphatase 1-mediated repression of mitogen and stress-activated protein kinase 1. Am J Respir Cell Mol Biol (2014) 0.83
Authors’ response to Persson C: primary lysis/necrosis of eosinophils and clinical control of asthma. Thorax (2013) 0.82
Insomnia patients' help-seeking experiences. Behav Sleep Med (2013) 0.82
Airway basement membrane perimeter in human airways is not a constant; potential implications for airway remodeling in asthma. J Appl Physiol (1985) (2004) 0.82
Rhinovirus-induced exacerbations of asthma: How is the {beta}2-adrenoceptor implicated? Am J Respir Cell Mol Biol (2009) 0.81
Experiences of community pharmacists involved in the delivery of a specialist asthma service in Australia. BMC Health Serv Res (2012) 0.81
Innovative asthma health promotion by rural community pharmacists: a feasibility study. Health Promot J Austr (2005) 0.80
Performance of a brief asthma control screening tool in community pharmacy: a cross-sectional and prospective longitudinal analysis. Prim Care Respir J (2014) 0.80
A pharmacy asthma service achieves a change in patient responses from increased awareness to taking responsibility for their asthma. Int J Pharm Pract (2014) 0.80
Unmet needs of older people with asthma: cross-sectional survey. J Asthma (2011) 0.79
Inappropriate prescribing of inhaled corticosteroids: are they being prescribed for respiratory tract infections? A retrospective cohort study. Prim Care Respir J (2013) 0.79
Questionnaire responses that predict airway response to hypertonic saline. Respiration (2005) 0.78
Cost is a major barrier to the use of inhaled corticosteroids for obstructive lung disease. Med J Aust (2009) 0.78
Th1 cytokine-induced syndecan-4 shedding by airway smooth muscle cells is dependent on mitogen-activated protein kinases. Am J Physiol Lung Cell Mol Physiol (2012) 0.78
Impact of graphic format on perception of change in biological data: implications for health monitoring in conditions such as asthma. Prim Care Respir J (2012) 0.77
Thiazolidinediones inhibit airway smooth muscle release of the chemokine CXCL10: in vitro comparison with current asthma therapies. Respir Res (2012) 0.77
Indices of bronchial reactivity and sensitivity. Thorax (2010) 0.76
Does the current stepwise approach to asthma pharmacotherapy encourage over-treatment? Respirology (2010) 0.75
Acceptability of willingness to pay techniques to consumers. Health Expect (2002) 0.75
Measuring peak flow enhances adherence to monitoring in asthma. Thorax (2007) 0.75
Single maintenance and reliever therapy (SMART) of asthma. Thorax (2010) 0.75
Treatment of mild asthma. N Engl J Med (2005) 0.75
Action needed on asthma plans. Prim Care Respir J (2011) 0.75
Assessment and management of asthma and chronic obstructive pulmonary disease in Australian general practice. Aust Fam Physician (2017) 0.75
Effect of mouthpiece washing on aerosol performance of CFC-free Ventolin. J Asthma (2004) 0.75
Characterizing asthma phenotypes: predictors and outcomes at the extremes of asthma severity. Respirology (2009) 0.75
The benefit of experience: patient perception of asthma self-management. Prim Care Respir J (2007) 0.75
Control charts demonstrated limited utility for the monitoring of lung function in asthma. J Clin Epidemiol (2011) 0.75
Increasing the dose of inhaled corticosteroid when asthma deteriorates--does it prevent severe exacerbations? Pol Arch Med Wewn (2010) 0.75
Lack of awareness of need to clean CFC-free metered-dose inhalers. J Asthma (2004) 0.75